Please login to the form below

Fleet Laboratories

Fleet Laboratories Ltd are part of the DDD Group of Companies which was established in 1912 and is still privately owned. We work with customers in the health and beauty industry manufacturing pharmaceutical products on behalf of the licence holder and developing and manufacturing toiletry products for both brand owners and retailers. We have a diverse range of customers, some of whom we have worked with for nearly 30 years. Depending on your business need, we have a flexible range of services available.

This is a FREE listing




Below are full profiles from other companies in this area

Company Details

Fleet Laboratories

Telephone:+44 (0)1923 229251

Contact

Address:
94 Rickmansworth Road
Watford Herts
WD18 7JJ
United Kingdom

Latest content from PMHub

OPEN Health attend EB World Congress—building on momentum and strength in numbers for epidermolysis bullosa
Ben Speller shares his thoughts on the value of disease specific congresses
OPEN Health
COUCH Health demands the clinical research industry improves participant diversity
As advocates of diverse and inclusive clinical trials, patient engagement agency COUCH Health is calling on the industry take action to make clinical research more inclusive and representative of all populations. Demand Diversity has launched with the aim to raise awareness of the lack of diversity in clinical research, and make change happen. COUCH Health
Using TRAVELLESS™ to provide tailored pharmaceutical training
In May 2020, Valid Insight were scheduled to travel to Grenoble to deliver the market access modules as part of the Advanced Master’s in Biotechnology & Pharmaceutical Management programme with Grenoble Ecole de Management, a French graduate business school. The course has participants from varied backgrounds, but all from roles within the pharmaceutical industry. Valid Insight
OPEN Health use PR to support clinical trial recruitment
International Clinical Trials Day finds clinical research in the spotlight like never before, with any news coming from the many studies into potential vaccines and treatments for SARS-CoV-2
OPEN Health